Omega Diagnostics (RVKA) Income Statement
Omega Diagnostics Income Statement
Last quarter (Q4 2025), Omega Diagnostics's total revenue was $3.11M, a decrease of 35.70% from the same quarter last year. In Q4, Omega Diagnostics's net income was $-5.43M. See Omega Diagnostics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| $ 6.97M | $ 8.33M | $ 9.77M | $ 7.55M | $ 8.54M | |
| $ 4.28M | $ 5.00M | $ 6.05M | $ 3.17M | $ 4.75M | |
| $ 5.32M | $ 5.64M | $ 6.58M | $ 5.95M | $ 5.33M | |
| Depreciation and Amortization | $ 653.00K | $ 615.00K | $ 650.00K | $ 591.00K | $ 1.29M |
| $ -392.00K | $ 2.20M | $ -73.00K | $ -2.65M | $ 360.00K | |
| $ -1.04M | $ -640.00K | $ -535.00K | $ -2.78M | $ -582.00K | |
| $ -3.38M | $ 2.21M | $ -210.00K | $ -473.00K | $ -358.00K | |
| $ -4.42M | $ 1.57M | $ -745.00K | $ -3.25M | $ -950.00K | |
| $ -5.83M | $ 1.57M | $ -328.00K | $ -3.86M | $ -11.33M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.02 | $ 0.01 | $ -0.00 | $ -0.02 | $ -0.06 |
| Diluted EPS | $ -0.02 | $ 0.01 | $ -0.00 | $ -0.02 | $ -0.06 |
| Weighted Average Shares Outstanding | 237.95M | 238.27M | 237.73M | 231.26M | 182.64M |
| Weighted Average Shares Outstanding (Diluted) | 237.95M | 238.27M | 238.10M | 231.26M | 182.64M |
Currency in GBP